360 related articles for article (PubMed ID: 24747643)
1. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
Goh G; Scholl UI; Healy JM; Choi M; Prasad ML; Nelson-Williams C; Kunstman JW; Korah R; Suttorp AC; Dietrich D; Haase M; Willenberg HS; Stålberg P; Hellman P; Akerström G; Björklund P; Carling T; Lifton RP
Nat Genet; 2014 Jun; 46(6):613-7. PubMed ID: 24747643
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study.
Li X; Wang B; Tang L; Lang B; Zhang Y; Zhang F; Chen L; Ouyang J; Zhang X
Clin Endocrinol (Oxf); 2016 Dec; 85(6):954-961. PubMed ID: 27296931
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
[TBL] [Abstract][Full Text] [Related]
4. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
[TBL] [Abstract][Full Text] [Related]
6. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
[TBL] [Abstract][Full Text] [Related]
7. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A defects and cortisol-producing adrenal tumors.
Zilbermint M; Stratakis CA
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
[TBL] [Abstract][Full Text] [Related]
9. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
[TBL] [Abstract][Full Text] [Related]
10. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
[TBL] [Abstract][Full Text] [Related]
11. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.
Baba R; Oki K; Gomez-Sanchez CE; Otagaki Y; Itcho K; Kobuke K; Kodama T; Nagano G; Ohno H; Yoneda M; Hattori N
Mol Cell Endocrinol; 2021 Dec; 538():111456. PubMed ID: 34520814
[TBL] [Abstract][Full Text] [Related]
12. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
[TBL] [Abstract][Full Text] [Related]
13. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
[TBL] [Abstract][Full Text] [Related]
14. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
[TBL] [Abstract][Full Text] [Related]
15. PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.
Berthon AS; Szarek E; Stratakis CA
Front Cell Dev Biol; 2015; 3():26. PubMed ID: 26042218
[TBL] [Abstract][Full Text] [Related]
16. Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma.
Tseng IC; Huang WJ; Jhuang YL; Chang YY; Hsu HP; Jeng YM
J Pathol; 2017 Jun; 242(2):134-139. PubMed ID: 28369983
[TBL] [Abstract][Full Text] [Related]
17. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
[TBL] [Abstract][Full Text] [Related]
18. A case of autonomous cortisol secretion in a patient with subclinical Cushing's syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone.
Sakaguchi C; Ashida K; Kohashi K; Ohe K; Fujii Y; Yano S; Matsuda Y; Sakamoto S; Sakamoto R; Oda Y; Nomura M; Ogawa Y
BMC Endocr Disord; 2019 Jan; 19(1):13. PubMed ID: 30670014
[TBL] [Abstract][Full Text] [Related]
19. cAMP signaling in cortisol-producing adrenal adenoma.
Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
[TBL] [Abstract][Full Text] [Related]
20. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
Hirsch TZ; Negulescu A; Gupta B; Caruso S; Noblet B; Couchy G; Bayard Q; Meunier L; Morcrette G; Scoazec JY; Blanc JF; Amaddeo G; Nault JC; Bioulac-Sage P; Ziol M; Beaufrère A; Paradis V; Calderaro J; Imbeaud S; Zucman-Rossi J
J Hepatol; 2020 May; 72(5):924-936. PubMed ID: 31862487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
